BioNexus Gene Lab (BGLC) Net Cash Flow Growth (3y) (2021 - 2026)
BioNexus Gene Lab (BGLC) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn | 37.18% |
| 2 | Sherwin Williams | 84.74 Bn | 84.44 Bn | 3.34 Bn | 11.83% |
| 3 | Ecolab | 78.90 Bn | 73.77 Bn | 1.95 Bn | - |
| 4 | Air Products & Chemicals | 68.19 Bn | 67.21 Bn | 1.04 Bn | 26.96% |
| 5 | Ppg Industries | 25.36 Bn | 23.77 Bn | 1.81 Bn | 35.68% |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn | - |
| 7 | LyondellBasell Industries | 21.91 Bn | 19.28 Bn | 2.04 Bn | -82.08% |
| 8 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn | -55.70% |
| 9 | DuPont de Nemours | 18.83 Bn | 17.09 Bn | 639.00 Mn | -8.25% |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 | 30.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.15% |
| Dec 31, 2025 | 42.24% |
| Sep 30, 2025 | -38.22% |
| Jun 30, 2025 | -35.92% |
| Mar 31, 2025 | -52.94% |
| Dec 31, 2024 | 16.25% |
| Sep 30, 2024 | -111.14% |
| Jun 30, 2024 | 23.64% |
| Mar 31, 2024 | 67.36% |
| Dec 31, 2023 | -73.63% |
| Sep 30, 2023 | 80.64% |
| Jun 30, 2023 | 40.66% |
| Mar 31, 2023 | -29.45% |
| Dec 31, 2022 | 71.62% |
| Sep 30, 2022 | 60.50% |
| Jun 30, 2022 | -79.77% |
| Mar 31, 2022 | -52.08% |
| Dec 31, 2021 | 58.68% |
| Mar 31, 2021 | -34.95% |